Bending the rules.
D019274:Botulinum Toxins, Type A / Q000009:adverse effects*; D002985:Clinical Protocols; D018849:Controlled Clinical Trials as Topic; D023381:Endpoint Determination; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*
D019274:Botulinum Toxins, Type A